The Combination of Fludarabine, Cyclophosphamide, and Granulocyte-Macrophage Colony-Stimulating Factor in the Treatment of Patients with Relapsed Chronic Lymphocytic Leukemia and Low-Grade Non-Hodgkin's Lymphoma-Reference-Cited by-同舟云学术

The Combination of Fludarabine, Cyclophosphamide, and Granulocyte-Macrophage Colony-Stimulating Factor in the Treatment of Patients with Relapsed Chronic Lymphocytic Leukemia and Low-Grade Non-Hodgkin's Lymphoma

Published:2005-06 Issue:1 Volume:6 Page:26-30
ISSN:1526-9655
Container-title:Clinical Lymphoma
language:en
Short-container-title:Clinical Lymphoma

Author:

Rao Ruta,Shammo Jamile M.,Enschede Sari H.,Porter Carlene,Adler Solomon S.,Venugopal Parameswaran,Gregory Stephanie A.

Publisher

Elsevier BV

Subject

Cancer Research

Reference21 articles.

1. Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia;O'Brien;Leukemia,1997

2. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective Tcell response;Kwak;Proc Natl Acad Sci,1996

3. Combined fludarabine, cyclophosphamide and rituximab achieves a high complete remission rate as initial treatment for chronic lymphocytic leukemia;Wierda;Blood,2001

4. Update of results on the combination of fludarabine, cyclophosphamide and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL);Garcia Manero;Blood,2001

5. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia;Rai;Blood,2000

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Polyphenolic Composition BP-C3 on the Efficacy and Hematological Toxicity of Cyclophosphamide in the Chemotherapy of Mice Bearing Soft Tissue Sarcomas Induced by Benzo[a]pyrene;Integrative Cancer Therapies;2019-01

2. Caesalpinia sappan L. heartwood ethanolic extract exerts genotoxic inhibitory and cytotoxic effects;Oriental Pharmacy and Experimental Medicine;2018-11-19

3. SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders;Expert Review of Hematology;2018-01-03

4. Efficacy and safety evaluation of fludarabine-based chemotherapy regimen for patients with non-Hodgkin lymphoma;Medicine;2017-08

5. Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2015-09